eNOS基因缺陷导致小鼠脑缺血损伤加重的内皮祖细胞机制研究

基本信息
批准号:81603097
项目类别:青年科学基金项目
资助金额:17.00
负责人:董晓慧
学科分类:
依托单位:同济大学
批准年份:2016
结题年份:2019
起止时间:2017-01-01 - 2019-12-31
项目状态: 已结题
项目参与者:何志高,刘莹,胥静,张誉艺,范秀丛,康乐
关键词:
内皮祖细胞凝血酶敏感蛋白2凝血酶敏感蛋白1内皮型一氧化氮合酶脑缺血损伤
结项摘要

The treatment of stroke is still a global problem to date, and it is necessary to investigate new therapeautic strategies for stroke. It is reported that endothelial nitric oxide synthase (eNOS) deficiency aggravates cerebral ischemic injury in mice, but the mechanisms are not fully understood. Endothelial progenitor cells (EPC) participate in angiogenesis that correlates inversely with the severity of cerebral ischemic injury. Our previous studies demonstrated that EPCs were dysfunctional in eNOS gene knockout (eNOS-/-) mice. Accordingly, we hypothesize that EPCs dysfunction and/or number reduction induced by eNOS deficiency aggravate cerebral ischemic injury. To test this hypothesis, this project will perform following 4 aims: 1) to determine the relationship between the aggravated cerebral ischemic injury and EPC dysfunction and/or number reduction in eNOS-/- mice; 2) to investigate the mechanisms underlying a defect of EPC mobilization in eNOS-/- mice; 3) to investigate the mechanisms underlying the EPC dysfunction in eNOS-/- mice; 3) to investigate the effects of EPC transplantation on cerebral ischemic injury in mice. Clinical trials show that a higher EPC number is related with a better prognosis in stroke patients, and EPCs may serve as a therapeutic target of cardio-cerebrovascular diseases. Therefore, this project may provide a new therapeutic strategy for cardio-cerebrovascular diseases, such as stroke.

目前脑卒中的治疗依然是个世界性难题,探索新治疗方法有现实的意义。内皮型一氧化氮合酶(eNOS)基因缺陷可加重小鼠的脑缺血损伤,但其机制尚不完全明确。脑缺血损伤的严重程度与血管新生有关,而血管新生与内皮祖细胞(EPC)的数量和功能密切相关。我们发现eNOS基因敲除小鼠EPC的功能出现失常。基于此,我们推测:eNOS基因缺陷导致小鼠的EPC功能和/或数量受损,从而加重小鼠的脑缺血损伤。本项目拟通过下列实验来验证该假设:确定eNOS基因缺陷加重脑缺血损伤与其导致EPC数量和/或功能损害的关系;初步探索eNOS基因缺陷小鼠EPC动员能力受损的机制;阐明eNOS基因缺陷导致EPC功能受损的机制;研究EPC移植对脑缺血损伤的治疗作用。临床研究证实,外周血中EPC数量高的脑卒中患者预后比较好,EPC可作为治疗心脑血管疾病的新靶点,所以本项目的研究有可能为脑卒中等心脑血管系统疾病的治疗提供新的思路。

项目摘要

众所周知,寻求有效的手段防治脑卒中具有极其重要的临床意义。我们的实验结果证实,内皮型一氧化氮合酶(eNOS)基因缺陷可加重小鼠的脑缺血损伤。脑缺血损伤严重的eNOS-/-小鼠血管新生数量也减少,而且血管新生数量的减少与内皮祖细胞(EPC)数量减少和功能降低密切相关。此外,实验结果还表明,eNOS基因缺陷小鼠EPC动员能力受损与EPC中氧自由基水平升高和NO水平下降有关,并可诱导凝血酶敏感蛋白-1 (TSP-1)和凝血酶敏感蛋白-2 (TSP-2)表达的增加,增加的TSP-1和TSP-2导致EPC功能失常;经体外干预,功能得到改善的eNOS基因敲除小鼠EPC对脑缺血损伤的治疗效果得到提高。因此,EPC可作为治疗心脑血管疾病的新靶点,同时也为脑卒中等心脑血管系统疾病的治疗提供新的思路。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation

Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation

DOI:
发表时间:2016
2

Intensive photocatalytic activity enhancement of Bi5O7I via coupling with band structure and content adjustable BiOBrxI1-x

Intensive photocatalytic activity enhancement of Bi5O7I via coupling with band structure and content adjustable BiOBrxI1-x

DOI:10.1016/j.scib.2017.12.016
发表时间:2018
3

Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling

Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling

DOI:10.1016/j.intimp.2021.107374
发表时间:2021
4

Asymmetric Synthesis of (S)-14-Methyl-1-octadecene, the Sex Pheromone of the Peach Leafminer Moth

Asymmetric Synthesis of (S)-14-Methyl-1-octadecene, the Sex Pheromone of the Peach Leafminer Moth

DOI:
发表时间:
5

An alternative conformation of human TrpRS suggests a role of zinc in activating non-enzymatic function

An alternative conformation of human TrpRS suggests a role of zinc in activating non-enzymatic function

DOI:10.1080/15476286.2017.1377868.
发表时间:2017

董晓慧的其他基金

相似国自然基金

1

老年小鼠脑缺血损伤加重的内皮祖细胞机制

批准号:81900243
批准年份:2019
负责人:彭程
学科分类:H0202
资助金额:20.00
项目类别:青年科学基金项目
2

MnSOD缺陷引起的内皮祖细胞功能障碍加重小鼠脑缺血损伤

批准号:81170115
批准年份:2011
负责人:谢和辉
学科分类:H0202
资助金额:60.00
项目类别:面上项目
3

非eNOS途径在ADMA致内皮祖细胞损伤中的作用及机制研究

批准号:81570239
批准年份:2015
负责人:柏勇平
学科分类:H0202
资助金额:60.00
项目类别:面上项目
4

长期摄入糖替代品加重小鼠脑缺血损伤的血管新生机制研究

批准号:81870189
批准年份:2018
负责人:谢和辉
学科分类:H0202
资助金额:57.00
项目类别:面上项目